FDA Inspection 1112685 — Sun-Ju Chung, M.D.
The FDA completed an inspection of Sun-Ju Chung, M.D. on November 22, 2019 in Seoul. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 22, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Seoul (Korea (the Republic of))
Additional Details
Clinical Investigator (CI)